ArticleFrontiers in cardiovascular medicine2022

Cardiovascular toxicity associated with angiogenesis inhibitors: A comprehensive pharmacovigilance analysis based on the FDA Adverse Event Reporting System database from 2014 to 2021.

YanFeng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.